An interesting observation, to be found towards the bottom of this article from MarketWatch:
"Gardasil has been somewhat controversial, as some parents are uncomfortable with giving pre-teens a vaccine to prevent sexually transmitted diseases.
But in the third quarter, Gardasil generated revenue of $418 million, roughly a third of the Whitehouse Station, N.J., company's sales from vaccines."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment